OCTOBIDPublic Tender GazetteImmune Tolerance Network (UM1 Clinical Trial Required)
Grant monitored from grants-gov.
- Buyer / agency
- National Institutes of Health
- Notice type
- Grant
- Solicitation number
- RFA-AI-28-005
- Posted
- October 20, 2026
- Response deadline
- January 29, 2027
- Location
- US
- Estimated value
- $27,000,000 USD
- NAICS
- Not supplied
- Source
- grants-gov
Summary
The purpose of this notice of funding opportunity (NOFO) is to support applications to continue the Immune Tolerance Network (ITN). The primary objective of the Network is to develop tolerogenic therapies for immune-mediated disorders. The three main clinical areas of work are: 1) Allergic diseases and asthma; 2) Autoimmune diseases; and 3) Immune-mediated consequences of transplantation. The core functions of the ITN include designing, conducting, and sharing the results of …
See the official source link, all documents, and the full solicitation text — and prepare a proposal working draft with AI — with a free Octobid account.
Summaries are indexed from official public sources; the issuing platform’s notice, documents, and amendments always control.